Is comprehensive geriatric testing guiding in the identification of multiple myeloma patients who are candidates for autologous stem cell transplantation? A prospective analysis
- 5 October 2022
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 101 (12) , 2691-2697
Abstract
Multiple myeloma (MM) is a hematological malignancy of older adults. This study aimed to investigate the differences in performance, comorbidity scores, and comprehensive geriatric assessment (CGA) before and after induction therapy in newly diagnosed MM patients, as well as the factors that may be associated with improved performance status after induction therapy. Thirty-seven consecutive patients aged 50 years and older, who were newly diagnosed with MM, were included in the study. The patients underwent performance status evaluation and CGA when first diagnosed and after 4 cycles of induction chemotherapy. The performance status of 11 patients (40.7%) changed after induction therapy. Improvement in performance status was significantly lower in patients who were frail according to the Fried frailty criteria and IMWG scores (60% vs. 25%, p = 0.04), (30.0% vs. 6.2%, p = 0.02), taking more than 2 medications due to comorbidities (p = 0.01, confidence interval 0.06–0.09) and those with renal involvement (80.0% vs. 18.7%, p = 0.002). Those with bone involvement were more prevalent among the patients whose performance status improved (87.5% and 50.0%, p = 0.03). This study demonstrated that performance status might improve after induction therapy. Results suggest that CGA before induction therapy can predict performance status change. These results might have implications for predicting at the time of diagnosis, whether an MM patient can be a transplant candidate after induction therapy.Keywords
This publication has 22 references indexed in Scilit:
- A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patientsHaematologica, 2017
- Efficacy and safety of autologous hematopoietic cell transplantation in elderly patients with multiple myeloma: a retrospective national multi-site cohort studyAnnals of Hematology, 2016
- Comprehensive geriatric assessment – a guide for the non‐specialistInternational Journal Of Clinical Practice, 2013
- Multiple Myeloma: An UpdateOman Medical Journal, 2013
- Fatigue, Sleep, Pain, Mood, and Performance Status in Patients With Multiple MyelomaCancer Nursing, 2011
- Features of Frailty Are Surprisingly Common in Adults 50 Years and Older Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT) in the Modern EraTransplantation and Cellular Therapy, 2011
- Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTBlood, 2005
- Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy?a pilot studySupportive Care in Cancer, 2004
- Frailty in Older Adults: Evidence for a PhenotypeThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2001
- Validation of the Cumulative Illness Rating Scale in a Geriatric Residential PopulationJournal of the American Geriatrics Society, 1995